Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors
Condition(s):Vulvar Atrophy; Breast Cancer; Genitourinary Syndrome of MenopauseLast Updated:February 22, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Vulvar Atrophy; Breast Cancer; Genitourinary Syndrome of MenopauseLast Updated:February 22, 2022Completed
Condition(s):Vulvar Diseases; Vulvar Atrophy; DermatosesLast Updated:June 6, 2023Recruiting
Condition(s):Lasers; Atrophy of Vagina; Atrophy VulvaLast Updated:August 9, 2022Terminated
Condition(s):Dyspareunia; Menopause; Sexual Activity; Atrophy VulvaLast Updated:November 30, 2022Not yet recruiting
Condition(s):Breast Cancer; Endometrial CancerLast Updated:July 23, 2021Completed
Condition(s):Vulvar Lichen SclerosusLast Updated:March 22, 2022Completed
Condition(s):Vulvovaginal AtrophyLast Updated:June 2, 2021Unknown status
Condition(s):Vulvar and Vaginal AtrophyLast Updated:November 14, 2017Completed
Condition(s):Atrophy; Vaginal DiseasesLast Updated:June 28, 2013Completed
Condition(s):Vulvar and Vaginal AtrophyLast Updated:December 1, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.